CARBOGEN AMCIS is a leading service provider CDMO, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development.

Pharmaceutical

Carbogen Amcis

Pascal Villemagne

Stéphanie Schlienger

René Wyss

Matthias Deuß

Melanie Anselm

Johan Nijenhuis

Thomas Schaub

Manfred Krucker

Ralf Wünsch

Gavin Alexander Schmid

Damien Bray

Alexander Kienhoefer

Ian Howells

Mohan Murthy

Dietmar Schröer

Cor Veldhuizen

Pirmin Bercher

Julie Pagenaud

Jessica Huang

Helen Caddy-Leach

James Tomlinson

Fabio Bibbo

Carl Baker

Mara Guzzetti

Angie Stevens

Harry Wong

François Baduel

Mike Weiss

Alan Fischer

Martin Schneider

Dieter Thüer

Stephan Fritschi

The Research and Development team at CARBOGEN AMCIS is responsible for advancing drug development through innovative scientific research and project management. They collaborate on various development programs, focusing on formulation, compliance, and quality assurance for both new and commercial products. This multidisciplinary team leverages expertise in chemistry, analysis, and regulatory standards to ensure successful drug commercialization, ultimately contributing to the pharmaceutical industry's growth.

Research and Development

Quality Control and Assurance

Project Management and Operations

Research and Development

About

Team members

Other teams at Carbogen Amcis

Quality Control and Assurance

Project Management and Operations